The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1149
ISSUE1149
February 3, 2003
Teriparatide (Forteo) for Osteoporosis
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Teriparatide (Forteo) for Osteoporosis
February 3, 2003 (Issue: 1149)
Teriparatide (ter i par' a tide; Forteo - Lilly), a recombinant segment of human parathyroid hormone, has been approved by the FDA for parenteral treatment of osteoporosis in post-menopausal women, and in men with idiopathic or hypogonadal...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.